Ohr Pharmaceutical, Inc.
[NASDAQ: OHRP]; based in New York, New York; incorporated in Delaware
Lead Plaintiff Deadline: 04/16/2018
Case #: 18-cv-1284
Court: USDC, Southern District of New York
Notes: Lead or Derivative Plaintiffs; Class Period is 6/24/2014 to 1/4/2018